Filing Flows › Camp4 Therapeutics (CAMP) › Q3 2026 › vs Q3 2025
Camp4 Therapeutics (CAMP) Q3 2026 vs Q3 2025 (year over year)
Camp4 Therapeutics's revenue rose $1.1M (+139%) from $795K in Q3 2025 to $1.9M in Q3 2026.
Camp4 Therapeutics, Q3 2026: revenue $1.9M (+139% year over year), operating margin -738.8%, net loss $29.0M, operating cash flow −$8.2M. The chart draws each line against Q3 2025, the increases inside each band.
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $1.9M | $795K | $1.1M | +139% |
| Net loss | $29.0M | $15.1M | $13.9M | +92% |
| Costs & expenses | $30.9M | $15.9M | $15.0M | +94% |
| Operating costs | $15.9M | $14.4M | $1.5M | +10% |
| Interest & other, net | $14.9M | $1.4M | $13.5M | +931% |
| Research & development | $11.4M | $9.8M | $1.6M | +16% |
| General & admin | $4.5M | $4.6M | −$102K | -2% |
| Operating cash sources | $29.0M | $15.1M | $13.9M | +92% |
| Depreciation & amortization | $523K | $416K | $107K | +26% |
| Share-based compensation | $2.0M | $984K | $1.0M | +106% |
| Working capital & other | $18.2M | $2.5M | $15.8M | +635% |
| Cash used in operations | $8.2M | $11.2M | −$3.1M | -27% |
| Net loss absorbed | $29.0M | $15.1M | $13.9M | +92% |
Questions
How much did Camp4 Therapeutics's revenue grow year over year in Q3 2026?
Camp4 Therapeutics's revenue rose $1.1M (+139%) from $795K in Q3 2025 to $1.9M in Q3 2026.